UNNECESSARY CARE Is Profit Driven Healthcare to Blame?

Total Page:16

File Type:pdf, Size:1020Kb

UNNECESSARY CARE Is Profit Driven Healthcare to Blame? OVERTREATMENT bmj.com News: Experts consider how to tackle overtreatment in US healthcare UNNECESSARY CARE (BMJ 2012;344:e3144) doc2doc Overdiagnosis: do we know when to stop? Discuss at doc2doc Is profit driven bmj.com/multimedia Jeanne Lenzer healthcare to blame? (pictured) investigates the harms of overtreatment A newly launched movement led by prominent doctors is challenging the basic assumption in US healthcare that more is better. Jeanne Lenzer reports t 8 am on her first day as an Medicare recipients alone each year. Overall, Medicaid Services; and Harvey Fineberg, presi- intern, Diane Meier attended the unnecessary interventions are estimated to dent of the Institute of Medicine, which co-hosted resuscitation of an 89 year old man account for 10-30% of spending on healthcare the meeting. with end stage congestive heart in the US, or $250bn-$800bn (£154bn-£490bn; Participants poured out examples of ram- failure. The staff shocked the man’s €190bn-€610bn) annually.2 pant overtreatment, ranging from the overuse heartA repeatedly. They tried four times to place of screening tests and imaging technology to an a central line. They injected pressors directly Signs of change epidemic of questionable surgery (tonsillectomies into his heart, stuck his femoral artery for blood Earlier in the year, Meier, along with more than alone increased by 74% from 1996 to 2006). gases, and performed chest compressions for over 130 prominent doctors from the US, Canada, Rita Redberg, a cardiologist and editor of the an hour before finally pronouncing him dead. and the UK participated in a two day conference Archives of Internal Medicine, told the gathering Two decades later, after witnessing similar pre- on avoiding avoidable care, the first in the US to that many interventions need to be challenged, death rituals countless times, Meier published focus exclusively on overtreatment. The gathering such as cardiac computed tomography, cancer the story of a 73 year old man with metastatic in Cambridge, Massachusetts, was co-convened screening for people over 75, and elective car- lung cancer who told his doctors he didn’t want by the Lown Cardiovascular Research Foundation diac angioplasties. She cited a study that found invasive testing and treatment. His doctors in Brookline, Massachusetts, and the New Amer- nearly half of elective percutaneous coronary consulted a psychiatrist, who said the man was ica Foundation, a Washington DC think tank. interventions (PCI) were either inappropriate or “in denial” about his illness. After some pressure The impetus for the meeting arose two years of “uncertain” benefit.4 She said, “Most patients from his doctors, the man and his family agreed ago, when Vikas Saini, a Harvard cardiologist and who are getting a PCI think that they are getting to further diagnostic testing and treatment, president of the Lown foundation, read Shannon it to prevent a heart attack and that they are going including placement of a gastrostomy tube. He Brownlee’s book, Overtreated: How Too Much to live longer.”5 Yet the only established benefit of was ultimately subjected to 47 Physicians are trained Medicine is Making Us Sicker and angioplasty for stable coronary disease is possible days of painful and invasive Poorer.3 Saini contacted Brown- relief of symptoms. treatments before dying.1 to believe that staving lee, who is acting director of The group identified multiple reasons that For Meier, who went on to off death, even if health policy at the New Amer- clinicians and hospitals overtreat, including win a MacArthur “genius grant” only for days, is their ica Foundation, and together, malpractice fears, supply driven demand, knowl- for her work in palliative care, it over‑riding mission, and they hatched a plan to convene edge gaps, biased research, profit seeking, patient was not the patient who was in all available technology the conference. Saini says, “We demand, and financial conflicts of guideline denial, but his doctors. Physi- should be employed to wanted to bring together the writers. Other commonly cited problems included cians are trained to believe that achieve that goal many people we knew who felt the rapid uptake of unproved technology and the staving off death, even if only for that the system was out of con- failure to inform patients fully of the potential days, is their over-riding mission, and all available trol in order to find out if there was enough com- harms of elective treatments. technology should be employed to achieve that mon purpose and commitment among them to try Several speakers emphasised the way physi- goal. The cost of this self delusion in Meier’s eyes to do something about unnecessary care.” cians are paid and trained in the US as central can be measured in the patient’s suffering, inad- The pair conceived of the meeting as a “big factors. Meier told the BMJ, “Medical students are equate pain relief, and in time lost that could have tent,” Saini says. “We wanted to jumpstart a con- taught to do things, not how to know what not to been spent at home with family and loved ones. versation within the clinical community about do. Medicine is a very action based profession, On a national level, the problem is daunting: our ethical obligations to avoid the harm caused and that’s how physicians in the US are paid, annually, 65% of all deaths in the United States to patients by overtreatment.” perhaps not coincidentally. You don’t get paid for now occur in hospitals, multiplying the instances The meeting attracted a who’s who of Ameri- telling people that watching and waiting might when futile or unnecessary care is given. can medicine, including Bernard Lown, inven- be best, or that keeping someone comfortable The harms of overtreatment are not restricted tor of the cardiac defibrillator and winner of might be better.” The result is that overtreatment to dying patients. Overly aggressive treatment the Nobel Peace prize; Donald Berwick, former is woven through American medical culture—as is estimated to cause 30 000 deaths among administrator of the US Centers for Medicare and one participant said, “It’s in the air we breathe.” BMJ | 6 OCTOBER 2012 | VOLUME 345 19 OVERTREATMENT There was general agreement on some solu- Inevitable opposition insured under the Aff ordable Care Act, interest tions: use guideline writers free of confl icts of While many of the Cambridge conference partici- in cutting costs has become a central topic in US interest, implement shared decision making, pants have been warning for decades about the politics, and overtreatment is increasingly a focus reduce excess hospital capacity, and reform tort harms of overtreatment, it is only now, with glo- in the clinical community. law. There was some disagreement about whether bal fi nancial downturns and growing awareness A fl urry of books, articles, international initia- the provisions in the recent Aff ordable Care Act of the unsustainability of healthcare spending, tives, and conferences focused on various aspects would reduce overtreatment. The majority that the issue is receiving signifi cant attention of overtreatment has appeared in the past few endorsed global payment schemes in a primary from the American media and politicians. With years. The American Board of Internal Medicine care driven system. some 30 million Americans expected to be newly announced its Choosing Wisely campaign in Is the USA’s problem ours too? The United Kingdom is fortunate in randomised controlled trials. investigating people who are that it is insulated against some Faced with the contract, GPs are unlikely to bene t. of the needless overtesting, made to ask themselves why a These campaigns are o en overtreating, and overdiagnosing patient is not taking a drug, rather pivotal to publicity by patient that doctors in the United States than why they should be. groups and charities. However, are rising up against. Instead, we A long campaign for fairer, nancial relations between these have the National Institute for better information on NHS groups and the drug industry— Health and Clinical Excellence screening—which was supported with its agendas for the uptake (NICE), which o ers evidence by one of the instigators of breast of new interventions and its PR based appraisals of healthcare screening in the UK, Professor expertise—are o en unclear. And interventions and screening and Michael Baum—looks like it may despite the continuing problems which protects against treatments have, at least in part, succeeded. of opaque data from clinical Did this UK campaign (above) lead to unnecessary chest x rays? of little or no e cacy being o ered The current review of information trials, earlier this year doctors on the NHS. We also have the UK given about screening tests in were told not to “accept the decide which treatments to fund. National Screening Committee, the UK is likely to recommend negative myths about cooperating Will this result in political whim, which provides critical reviews balanced information on the with industry” in guidance rather than evidence based, and recommendations of what pros and cons of screening and supported by numerous colleges, decision making? The Health screening is e ective and useful. promote informed choice. There medical journals, the BMA, and and Social Care Act has given Does this mean that we can is no doubt that screening causes the Association of the British permission for the dissolution of relax? Unfortunately not. The overdiagnosis and overtreatment. Pharmaceutical Industry. the NHS into a mere brand, and general practice contract has However, private screening clinics, Shopping last month, I was with competition companies who improved the quanti cation of of which there are many, thrive. handed leaflets from a stall are likely to fragment care despite what we do, but the price of this is Similar problems are created demanding “awareness” about evidence that continuity results that more patients are exposed to by non-evidenced awareness restless legs, suggesting I could in less intervention and better guidelines rich in pharmaceutical campaigns.
Recommended publications
  • Overdiagnosis and Overtreatment Over Time
    University of Massachusetts Medical School eScholarship@UMMS Family Medicine and Community Health Publications and Presentations Family Medicine and Community Health 2015-6 Overdiagnosis and overtreatment over time Stephen A. Martin University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/fmch_articles Part of the Community Health and Preventive Medicine Commons, Diagnosis Commons, Family Medicine Commons, Preventive Medicine Commons, and the Primary Care Commons Repository Citation Martin SA, Podolsky SH, Greene JA. (2015). Overdiagnosis and overtreatment over time. Family Medicine and Community Health Publications and Presentations. https://doi.org/10.1515/dx-2014-0072. Retrieved from https://escholarship.umassmed.edu/fmch_articles/318 Creative Commons License This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Family Medicine and Community Health Publications and Presentations by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. Diagnosis 2015; 2(2): 105–109 Opinion Paper Open Access Stephen A. Martin*, Scott H. Podolsky and Jeremy A. Greene Overdiagnosis and overtreatment over time Abstract: Overdiagnosis and overtreatment are often Introduction thought of as relatively recent phenomena, influenced by a contemporary combination of technology, speciali- In recent years, an increasing number of clinicians, jour- zation, payment models, marketing, and supply-related nalists, health service researchers, and policy-makers demand. Yet a quick glance at the historical record reveals have drawn attention to the problems of overdiagnosis that physicians and medical manufacturers have been and the overtreatment that it so often engenders [1, 2].
    [Show full text]
  • Medicalisation and Overdiagnosis: What Society Does to Medicine Wieteke Van Dijk*, Marjan J
    http://ijhpm.com Int J Health Policy Manag 2016, 5(11), 619–622 doi 10.15171/ijhpm.2016.121 Perspective Medicalisation and Overdiagnosis: What Society Does to Medicine Wieteke van Dijk*, Marjan J. Faber, Marit A.C. Tanke, Patrick P.T. Jeurissen, Gert P. Westert Abstract The concept of overdiagnosis is a dominant topic in medical literature and discussions. In research that Article History: targets overdiagnosis, medicalisation is often presented as the societal and individual burden of unnecessary Received: 2 May 2016 medical expansion. In this way, the focus lies on the influence of medicine on society, neglecting the possible Accepted: 23 August 2016 influence of society on medicine. In this perspective, we aim to provide a novel insight into the influence of ePublished: 31 August 2016 society and the societal context on medicine, in particularly with regard to medicalisation and overdiagnosis. Keywords: Medicalisation, Overdiagnosis, Society Copyright: © 2016 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http:// creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. *Correspondence to: Citation: van Dijk W, Faber MJ, Tanke MA, Jeurissen PP, Westert GP. Medicalisation and overdiagnosis: Wieteke van Dijk what society does to medicine. Int J Health Policy Manag. 2016;5(11):619–622. doi:10.15171/ijhpm.2016.121
    [Show full text]
  • BOOKTIVISM: the Power of Words
    BOOKTIVISM: The Power of Words Book•ti•vi•sm(noun). 1. The mobilization of groups of concerned citizens produced by reading books offering powerful analyses of social or political issues. 2. A call to action based on the sharing of knowledge through books. 3. Books + activism = “booktivism.” 4. A term first used at the SellingSickness, 2013: People Before Profits conference in Washington, DC, see www.sellingsickness.com. Read. Discuss. Be thoughtful. Be committed. Here are some more suggestions to get you started: 1) Set up a reading group on disease-mongering among interested friends and colleagues. If you do The books included in BOOKTIVISM celebrate recent contributions to the broad topic of disease- not already have a group of interested readers, post a notice in your workplace, library, community mongering, especially as they examine the growing prevalence and consequences of overtreatment, center, apartment building, etc. Once you have a group, decide where to meet. Book clubs can overscreening, overmarketing, and overdiagnosis (see Lynn Payer’s 1992 classic, Disease-Mongers: How meet anywhere – at homes, in dorms, in pubs, in coffeehouses, at libraries, even online! Decide on Doctors, Drug Companies, and Insurers Are Making You Feel Sick, for an introduction to timing and format. Will you meet monthly/bimonthly? You’ll need time to prepare for the sessions, disease-mongering). but not so much time that you lose touch. Circulate the reading guide. It is usually best if one person leads each discussion, to have some questions at the ready and get things rolling. Although the challenge to disease-mongering is not unprecedented (the women’s health movement of the 1970s was another key historical moment), these books represent an impressive groundswell OR, maybe you’d like to of amazing, powerful, brilliant, and often deeply unsettling investigations by physicians, health scientists, 2) Set up a lecture/discussion group.
    [Show full text]
  • Overdiagnosis: Causes and Consequences in Primary Health Care
    PREVENTION IN PRACTICE A SERIES FROM THE CANADIAN TASK FORCE Overdiagnosis: causes and consequences in primary health care Harminder Singh MD MPH FRCPC James A. Dickinson MBBS PhD CCFP FRACGP Guylène Thériault MD CCFP Roland Grad MDCM MSc CCFP FCFP Stéphane Groulx MD CCFP FCFP Brenda J. Wilson MBChB MSc MRCP(UK) FFPH Olga Szafran MHSA Neil R. Bell MD SM CCFP FCFP verdiagnosis was well recognized in the second year ago. She underwent a lumpectomy and radiation half of the 20th century from the advent of wide- therapy. Linda believes that mammography saved her spread screening for cancers.1,2 However, over- life and becomes a breast cancer screening advocate. Odiagnosis has received much more widespread attention For the past year, she has been telling her 50-year-old by health care providers and policy makers in the 21st daughter Sarah to undergo mammography. Your col- century following the seminal writings by Welch and league, who is their physician, is just back from a con- Black.3 Initially, there was astonishment that diagnosis ference and wonders if Linda was diagnosed with a of a disorder such as cancer might not be of beneft. cancer that was not destined to alter her life if it had Overdiagnosis remains a diffcult concept to commu- remained undetected (ie, was she overdiagnosed?). He nicate to the public, most of whom are unaware of the brings up the cases for discussion at monthly rounds in issue.4 The public, and many in the medical profession, are attuned to the idea that prevention is better than your group practice.
    [Show full text]
  • An Overview on High Health Care Costs in the US, Overdiagnosis, and Health Care Value
    An Overview on High Health Care Costs in the US, Overdiagnosis, and Health Care Value Michael Tjahjadi, M.D. James Stallworth, M.D. Disclosures Neither Dr. Tjahjadi nor Dr. Stallworth has any financial incentives or relationships to disclose. The Healthcare System of the US We may have heard the phrases: Our healthcare system is broken Our spending in healthcare is unsustainable The US spends 2.5 times as much on health care as peer nations Yet some US outcomes trail peer nations Highest infant mortality rate Highest obesity rate US worst among high income countries when measured by specific population health outcomes Fairbrother et al, Pediatrics, June 2015 Ice-Breaker Question Is it too conflictual to ask clinicians to be cost-conscious and at the same time keep the welfare of the patient foremost in their minds? Yes No It depends Illustrative Case #1 15 year old AA male with SS trait presents with a 20 pound weight loss over 3 months despite an “ok” appetite. No change in bowel habits, no fever. He denies sexual activity and drug use, no history of blood transfusions and no other symptoms. He denies being depressed. On PE, he is quite thin with decreased subcutaneous tissue. His VS are stable but a HR of 110. He has no thrush, lymphadenopathy or HSM. He is Tanner 3. His exam is otherwise non revealing. From a health care value perspective, would you order an HIV? Illustrative Case #2 In June, a 22 mo previously healthy child presents with a 2 day history of diarrhea, 1 day of which is now bloody.
    [Show full text]
  • Evidence for Overuse of Medical Services Around the World
    Series Right care 1 Evidence for overuse of medical services around the world Shannon Brownlee, Kalipso Chalkidou, Jenny Doust, Adam G Elshaug, Paul Glasziou, Iona Heath*, Somil Nagpal, Vikas Saini, Divya Srivastava, Kelsey Chalmers, Deborah Korenstein Lancet 2017; 390: 156–68 Overuse, which is defined as the provision of medical services that are more likely to cause harm than good, is a Published Online pervasive problem. Direct measurement of overuse through documentation of delivery of inappropriate services is January 8, 2017 challenging given the difficulty of defining appropriate care for patients with individual preferences and needs; overuse http://dx.doi.org/10.1016/ can also be measured indirectly through examination of unwarranted geographical variations in prevalence of S0140-6736(16)32585-5 procedures and care intensity. Despite the challenges, the high prevalence of overuse is well documented in high-income This is the first in a Series of four papers about right care countries across a wide range of services and is increasingly recognised in low-income countries. Overuse of unneeded See Comment pages 101, 102, services can harm patients physically and psychologically, and can harm health systems by wasting resources and and 105 deflecting investments in both public health and social spending, which is known to contribute to health. Although Lown Institute, Brookline, MA, harms from overuse have not been well quantified and trends have not been well described, overuse is likely to be USA (S Brownlee MSc, increasing worldwide.
    [Show full text]
  • National Cancer Institute University of Oxford
    SEPTEMBER 1-3, 2015 CO-SPONSORED BY NATIONAL CANCER INSTITUTE Division of Cancer Prevention UNIVERSITY OF OXFORD Centre for Evidence-Based Medicine NATCHER CONFERENCE CENTER National Institutes of Health | Bethesda, Maryland USA NOTICE OF PHOTOGRAPHY & FILMING Preventing Overdiagnosis 2015 is being visually documented. By your attendance you acknowledge that you have been informed that you may be photographed and recorded during this event . Images taken will be treated as property of Preventing Overdiagnosis and may be used in the future for promotional purposes. These images may be used without limitation by any organisation approved by the Preventing Overdiagnosis scientific committee and edited prior to publication as seen fit for purpose. Images will be available on the Internet, accessible to Internet users throughout the world including countries that may have less extensive data protection laws than partnering organisation countries. All films will be securely stored on the University of Oxford servers. Please make your- self known at the registration desk if you wish to remain off camera. Thank you for your cooperation. CONFERENCE PARTNERS The Dartmouth Institute Bond University, Centre for Research in Evidence-Based Practice The BMJ Consumer Reports University of Oxford, Centre for Evidence-Based Medicine The views expressed in these materials or by presenters or participants at the event do not necessarily reflect the official policies of the U.S. Department of Health and Human Services, the National Institutes of Health, the National Cancer Institute, or any NIH component. TABLE OF CONTENTS WELCOME 2015 Scientific Committee 4 KEYNOTES BIOS 6 PROGRAMME 16 KEYNOTE ABSTRACTS 32 WORKSHOP ABSTRACTS 34 SEMINAR ABSTRACTS 48 PANEL SESSION ABSTRACTS 61 POSTERS 66 NOTES 67 MAPS WELCOME We are pleased to welcome you to the 3rd Preventing Overdiagnosis conference, held in Bethesda, Maryland on the campus of the US National Institutes of Health.
    [Show full text]
  • Overtreatment and Informed Consent: a Fraud-Based Solution to Unwanted and Unnecessary Care
    OVERTREATMENT AND INFORMED CONSENT: A FRAUD-BASED SOLUTION TO UNWANTED AND UNNECESSARY CARE ISAAC D. BUCKt ABSTRACT According to multiple accounts, the administrationof American health care results in as much as $800 billion in wasted spending due largely to the provision of overly expensive, inefficient, and unnecessary services. Beyond inflictingfiscal pain on the nation'spocketbook, this waste has no clinical benefit-and often results in unnecessary hospital stays, cascading follow-up procedures, and time-wasting inconvenience for American patients. But aside from the mere annoyance of unnecessary care, the administrationof overtreatment-thatis, unnec- essary care in and of itself-causes harm to the patient. Excessive care is deficient care. Un- necessary care risks potential medical error and infection, and often subjects the patient to excessive recovery and rehabilitation. In addition to the fiscal reasons, it is not a stretch to observe that it makes little or no sense for American patients to desire unnecessary care. But yet, as a general matter, today's modern and patient-protective legal and bioethical framework governing American health carepurportedly forcefully protects patients from un- desirable care by requiring their informed consent before any procedure or service. The im- portanceof informed consent is well settled, and it is recognized as a sacred value in American health care. In law and bioethics, this value is so sanctified that in cases where providers fail to achieve informed consent, legal recourse is availablefor the wronged patient. The prevalence of overtreatment, when juxtaposed with the sanctity of informed consent, is a perplexing legal and policy-based problem. Specifically, this disconnect that results- between the robust protection of informed consent and patient autonomy on one hand, and the naggingproblem of undesirableand harmful overtreatment on the other-calls out for a reasoned legal resolution.
    [Show full text]
  • What Is Overdiagnosis and Why Should We Take It Seriously in Cancer Screening?
    July 2017; Vol. 27(3):e2731722 https://doi.org/10.17061/phrp2731722 www.phrp.com.au Perspective What is overdiagnosis and why should we take it seriously in cancer screening? Stacy M Cartera,c and Alexandra Barrattb a Centre for Values, Ethics and the Law in Medicine, University of Sydney, NSW, Australia b Sydney School of Public Health, University of Sydney, NSW, Australia c Corresponding author: [email protected] Article history Abstract Publication date: July 2017 Overdiagnosis occurs in a population when conditions are diagnosed correctly Carter SM, Barratt A. What is overdiagnosis but the diagnosis produces an unfavourable balance between benefts and and why should we take it seriously in harms. In cancer screening, overdiagnosed cancers are those that did not cancer screening? Public Health Res Pract. need to be found because they would not have produced symptoms or led to 2017;27(3):e2731722. premature death. These overdiagnosed cancers can be distinguished from false https://doi.org/10.17061/phrp2731722 positives, which occur when an initial screening test suggests that a person is at high risk but follow-up testing shows them to be at normal risk. The cancers most likely to be overdiagnosed through screening are those of the prostate, Key points thyroid, breast and lung. Overdiagnosis in cancer screening arises largely from the paradoxical problem that screening is most likely to fnd the slow-growing • An overdiagnosed cancer is correctly or dormant cancers that are least likely to harm us, and less likely to fnd the diagnosed but would not have produced aggressive, fast-growing cancers that cause cancer mortality.
    [Show full text]
  • Medical Errors, Malpractice, and Defensive Medicine: an Ill-Fated Triad
    Diagnosis 2017; 4(3): 133–139 Review Leonard Berlin* Medical errors, malpractice, and defensive medicine: an ill-fated triad DOI 10.1515/dx-2017-0007 Received February 22, 2017; accepted June 9, 2017; previously published online August 14, 2017 Abstract: For the first 180 years following the founding of the US, physicians occasionally were sued for medi- cal malpractice. Allegations of negligence were errors of commission – i.e. the physician made a mistake by doing something wrong, usually mistreatment of a frac- ture or dislocation, a complication or death following a surgical procedure, prescribing the wrong medication, and after the discovery of the X-ray by Roentgen in 1895, causing radiation burns. In the mid twentieth century malpractice allegations slowly changed from errors of commission to errors of omission – i.e. the physician failed to do something right: almost always, failed to make a diagnosis. The number of malpractice lawsuits increased at a geometric rate beginning in the 1960s, The Beginning and in the 1970s physicians began practicing defensive medicine, which lead physicians to order unnecessary I765: British legal scholar Sir William Blackstone pub- radiology exams and tests. In the past 20 years the lishes a compendium of legal principles entitled Commen- number of malpractice lawsuits has been decreasing, taries on the Laws of England in which he refers to “Mala but the practice of defensive medicine has continued. Praxis,” which he defines as “Neglect or unskillful man- Unnecessary exams and tests increase the likelihood agement of a physician or surgeon” [2]. It is from this term of overdiagnosis and overtreatment, i.e.
    [Show full text]
  • Why Clinicians Overtest: Development of a Thematic Framework Justin H
    Lam et al. BMC Health Services Research (2020) 20:1011 https://doi.org/10.1186/s12913-020-05844-9 RESEARCH ARTICLE Open Access Why clinicians overtest: development of a thematic framework Justin H. Lam* , Kristen Pickles, Fiona F. Stanaway† and Katy J. L. Bell† Abstract Background: Medical tests provide important information to guide clinical management. Overtesting, however, may cause harm to patients and the healthcare system, including through misdiagnosis, false positives, false negatives and overdiagnosis. Clinicians are ultimately responsible for test requests, and are therefore ideally positioned to prevent overtesting and its unintended consequences. Through this narrative literature review and workshop discussion with experts at the Preventing Overdiagnosis Conference (Sydney, 2019), we aimed to identify and establish a thematic framework of factors that influence clinicians to request non-recommended and unnecessary tests. Methods: Articles exploring factors affecting clinician test ordering behaviour were identified through a systematic search of MedLine in April 2019, forward and backward citation searches and content experts. Two authors screened abstract titles and abstracts, and two authors screened full text for inclusion. Identified factors were categorised into a preliminary framework which was subsequently presented at the PODC for iterative development. Results: The MedLine search yielded 542 articles; 55 were included. Another 10 articles identified by forward-backward citation and content experts were included, resulting
    [Show full text]
  • Position Paper on Overdiagnosis and Action to Be Taken
    POSITION PAPER ON OVERDIAGNOSIS AND ACTION TO BE TAKEN BY WONCA EUROPE THE WORLD ORGANIZATION OF FAMILY DOCTORS IN THE EUROPEAN REGION Modern medicine has brought impressive benefits to humankind. A side-effect of its many successes is however an unfounded, cultural belief that more medicine is necessarily better, irrespective of context. Consequently, problems related to “too much medicine”, overdiagnosis and overtreatment are on the rise. Ever more methods of surveillance, investigation and treatment become available, and health anxiety has become widespread. Unwarranted medical activity leads to unnecessary waste of resources, more inequalities in healthcare and, at worst, direct harm to patients and healthy citizens. In order to avert the further escalation of overdiagnosis there is a need to reassess and disseminate new evidence on timely and appropriate diagnostic processes along with the communication skills needed to inform patients and their families about the relevant significance of their diagnoses. Most general practitioners/family physicians (GPs/FPs) work in the clinical setting, which represents the patient’s first contact with the healthcare system, providing easy access and help with the whole range of health problems, regardless of age, sex and other personal characteristics. Furthermore, many GPs/FPs also carry administrative, academic and teaching responsibilities/opportunities. They may be involved in teams locally, regionally, nationally, and sometimes globally. In total, European GPs/FPs have many opportunities to influence the evolution of healthcare. This introduces a professional responsibility for GPs/FPs to observe and analyse the development, and take action. WONCA Europe wants to strengthen the ability of GPs/FPs to exercise sound professional judgment in their clinical practice, informed by best evidence (The European Definition of General Practice / Family Medicine 2011).
    [Show full text]